Primary Patient-Derived Cancer Cells and Their Potential for Personalized Cancer Patient Care

Por Kodack, David P., Farago, Anna F., Dastur, Anahita, Held, Matthew A., Dardaei, Leila, Friboulet, Luc, von Flotow, Friedrich, Damon, Leah J., Lee, Dana, Parks, Melissa, Dicecca, Richard, Greenberg, Max, Kattermann, Krystina E., Riley, Amanda K., Fintelmann, Florian J., Rizzo, Coleen, Piotrowska, Zofia, Shaw, Alice T., Gainor, Justin F., Sequist, Lecia V., Niederst, Matthew J., Engelman, Jeffrey A., Benes, Cyril H.
Publicado no Cell Rep (2017)

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer

Por Yoda, Satoshi, Lin, Jessica J., Lawrence, Michael S., Burke, Benjamin J., Friboulet, Luc, Langenbucher, Adam, Dardaei, Leila, Prutisto-Chang, Kylie, Dagogo-Jack, Ibiayi, Timofeevski, Sergei, Hubbeling, Harper, Gainor, Justin F., Ferris, Lorin A., Riley, Amanda K., Kattermann, Krystina E., Timonina, Daria, Heist, Rebecca S., Iafrate, A. John, Benes, Cyril H., Lennerz, Jochen K., Mino-Kenudson, Mari, Engelman, Jeffrey A., Johnson, Ted W., Hata, Aaron N., Shaw, Alice T.
Publicado no Cancer Discov (2018)